EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Morgan, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Morgan, J. P.
Experimental Biology and Medicine 227:336-344 (2002)
© 2002 Society for Experimental Biology and Medicine


ORIGINAL ARTICLE

Mibefradil Improves ß-Adrenergic Responsiveness and Intracellular Ca2+ Handling in Hypertrophied Rat Myocardium

Jiang-Yong Min*, Achim Meissner{dagger}, Jianan Wang* and James P. Morgan*,1

* Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; and
{dagger} Cardiovascular Division, Soest City Hospital of Munster University Medical School, Soest, Germany

The present study investigated the effects of mibefradil, a novel T-type channel blocker, on ventricular function and intracellular Ca2+ handling in normal and hypertrophied rat myocardium. Ca2+ transient was measured with the bioluminescent protein, aequorin. Mibefradil (2 µM) produced nonsignificant changes in isometric contraction and peak systolic intracellular Ca2+ concentration ([Ca2+]i) in normal rat myocardium. Hypertrophied papillary muscles isolated from aortic-banded rats 10 weeks after operation demonstrated a prolonged duration of isometric contraction, as well as decreased amplitudes of developed tension and peak Ca2+ transient compared with the sham-operated group. Additionally, diastolic [Ca2+]i increased in hypertrophied rat myocardium. The positive inotropic effect of isoproterenol stimulation was blunted in hypertrophied muscles despite a large increase in Ca2+ transient amplitude. Afterglimmers and corresponding aftercontractions were provoked with isoproterenol (10-5 and 10-4 M) stimulation in 4 out of 16 hypertrophied muscles, but were eliminated in the presence of mibefradil (2 µM). In addition, hypertrophied muscles in the presence of mibefradil had a significant improvement of contractile response to isoproterenol stimulation and a reduced diastolic [Ca2+]I, although a mild decrease of peak Ca2+-transient was also shown. However, verapamil (2 µM) did not restore the inotropic and Ca2+ modulating effects of isoproterenol in hypertrophied myocardium. Mibefradil partly restores the positive inotropic response to ß-adrenergic stimulation in hypertrophied myocardium from aortic-banded rats, an effect that might be useful in hypertrophied myocardium with impaired [Ca2+]i homeostasis.

Key Words: hypertrophied myocardium • intracellular Ca2+ • mibefradil







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Experimental Biology and Medicine.